Isolated cutaneous aspergillosis in an acute lymphoblastic leukemia patient after allogeneic stem cell transplantation | Zendy

Özlem Güzel Tunçcan | Zendy; Şahika Zeynep Akı | Zendy; Nalân Akyürek | Zendy; Gülsan Türköz Sucak | Zendy; Esin Şenol | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Isolated cutaneous aspergillosis in an acute lymphoblastic leukemia patient after allogeneic stem cell transplantation

Author(s) -

Özlem Güzel Tunçcan,

Şahika Zeynep Akı,

Nalân Akyürek,

Gülsan Türköz Sucak,

Esin Şenol

Publication year - 2011

Publication title -

the journal of infection in developing countries

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.322

H-Index - 49

eISSN - 2036-6590

pISSN - 1972-2680

DOI - 10.3855/jidc.1466

Subject(s) - medicine , voriconazole , aspergillosis , hematopoietic stem cell transplantation , stem cell , transplantation , refractory (planetary science) , leukemia , mesenchymal stem cell , acute leukemia , dermatology , immunology , pathology , surgery , antifungal , biology , astrobiology , genetics

Cutaneous aspergillosis is very rare and occurs predominantly in immunocompromised patients including transplant recipients. We report a 26-year-old male with acute lymphoblastic leukemia who developed cutaneous aspergillosis after undergoing combined immunosuppressive treatment including corticosteroid, cyclosporine A, mychophenolate mofetil and mesenchymal stem cells for steroid refractory skin acute graft versus host disease after myeloablative haematopoietic stem cell transplantation. The patient was treated with oral voriconazole therapy and recovered partially.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research